The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management
Product Description
The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management
This Fourth Edition of The Generic Challenge provides important new updates on current regulatory, legal and commercial issues affecting brand and generic pharmaceutical products, including new laws establishing generics for biologics, and changes brought about by the recently enacted America Invents Act. It explains clearly and understandably the roles of patents, FDA regulation of drugs and the Hatch Waxman Act in commercial drug development in light of generic challenges and how improvements in innovative drug products provide benefits to patients while extending the commercial lives of the drugs. There is simply no other book of its kind available on this important subject.
Technical Specifications
You might also like
Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand
Genentech: The Beginnings of Biotech (Synthesis)
Science Lessons: What the Business of Biotech Taught Me About Management
The BioTech Primer
Generic: The Unbranding of Modern Medicine
New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients
The Antidote: Inside the World of New Pharma
The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management (Fifth Edition)
Active Pharmaceutical Ingredients: Development, Manufacturing, and Regulation, Second Edition (Drugs and the Pharmaceutical Sciences)
Valuation in Life Sciences: A Practical Guide